bioAffinity Technologies, Inc.

BIAFW · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$5,051-$4,061-$2,660-$2,967
Dep. & Amort.$113$113$155$154
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$212$327$234
Change in WC-$357$26$537$902
Other Non-Cash$2,815$1,063$0$0
Operating Cash Flow-$2,480-$2,647-$1,642-$1,677
Investing Activities
PP&E Inv.$4-$13-$51-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$4-$13-$51-$0
Financing Activities
Debt Repay.$43-$167-$139-$188
Stock Issued$10,718$2,798$1,171$2,186
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$1,418$387$0$28
Financing Cash Flow$9,343$3,019$1,032$2,026
Forex Effect$0$0$0$0
Net Chg. in Cash$6,866$358-$661$349
Supplemental Information
Beg. Cash$803$445$1,105$757
End Cash$7,669$803$445$1,105
Free Cash Flow-$2,477-$2,661-$1,693-$1,677